Reassessment of the role of the central cholinergic system

Journal of Molecular Neuroscience

Volumn 53, Issue 3, 2014, Pages 352-358

  Hrabovska, Anna ^a   Krejci, Eric ^b  

^a Faculty of Natural Sciences   (Slovakia)

^b CNRS   (France)

Author keywords

Acetylcholinesterase; Central cholinergic system; Cholinesterase inhibitors; Cognitive functions; Motor functions; Thermoregulation

Indexed keywords

ACETYLCHOLINE; ACETYLCHOLINESTERASE; CHOLINERGIC RECEPTOR STIMULATING AGENT; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; DONEPEZIL; GALANTAMINE; METHYLSCOPOLAMINE; NICOTINIC RECEPTOR; OXOTREMORINE; RIVASTIGMINE;

ALTERNATIVE RNA SPLICING; ALZHEIMER DISEASE; ARTICLE; BODY TEMPERATURE; CHOLINERGIC SYNAPSE; CHOLINERGIC SYSTEM; COGNITION; DRUG EFFECT; GENOTYPE; HUMAN; MAZE TEST; MOTOR CONTROL; MOTOR COORDINATION; MOTOR PERFORMANCE; NONHUMAN; OLIGOMERIZATION; PARKINSON DISEASE; PASSIVE AVOIDANCE; PATHOPHYSIOLOGY; PHYSIOLOGICAL PROCESS; SOCIAL RECOGNITION TEST; SPATIAL MEMORY; THERMOREGULATION; TRANSGENIC MOUSE; ANIMAL; BRAIN; METABOLISM; PHYSIOLOGY;

MUS;

ACETYLCHOLINE; ANIMALS; BODY TEMPERATURE REGULATION; BRAIN; CHOLINESTERASES; COGNITION; HUMANS; MOTOR SKILLS;

EID: 84905051871     PISSN: 08958696     EISSN: 15591166     Source Type: Journal    
DOI: 10.1007/s12031-013-0164-8     Document Type: Article

References (60)

1. Abitbol M, Menini C, Delezoide AL, Rhyner T, Vekemans M, Mallet J (1993) Nucleus basalis magnocellularis and hippocampus are the major sites ofFMR-1 expression in the human fetal brain. Nat Genet 4:147-153 (Pubitemid 23179098)
2. Apicella P (2007) Leading tonically active neurons of the striatum from reward detection to context recognition. Trends Neurosci 30:299-306
3. Bartus RT, Dean RL III, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217:408-414
4. Bernard V, DécossasM, Liste I, Bloch B (2006) Intraneuronal trafficking of G-protein-coupled receptors in vivo. Trends Neurosci 29:140-147
5. Bernard V, Girard E, Hrabovska A, Camp S, Taylor P, Plaud B, Krejci E (2011) Distinct localization of collagen Q and PRiMA forms of acetylcholinesterase at the neuromuscular junction. Mol Cell Neurosci 46:272-281
6. Blong RM, Bedows E, Lockridge O (1997) Tetramerization domain of human butyrylcholinesterase is at the C-terminus. Biochem J 327(Pt 3):747 -757
7. Bohnen NI, Albin RL (2011) The cholinergic system and Parkinson disease. Behav Brain Res 221:564-573
8. Bohnen NI, Müller MLTM, Kotagal V, Koeppe RA, Kilbourn MR, Gilman S, Albin RL, Frey KA (2012) Heterogeneity of cholinergic denervation in Parkinson's disease without dementia. J Cereb Blood Flow Metab Off J Int Soc Cereb Blood Flow Metab 32:1609-1617
9. Bonsi P, Cuomo D, Martella G, Madeo G, Schirinzi T, Puglisi F, Ponterio G, Pisani A (2011) Centrality of striatal cholinergic transmission in basal ganglia function. Front Neuroanat 5:6
10. Bouvier M, Collins S, O'Dowd BF, Campbell PT, de Blasi A, Kobilka BK, MacGregor C, Irons GP, CaronMG, Lefkowitz RJ (1989) Two distinct pathways for cAMP-mediated down-regulation of the beta 2-adrenergic receptor. Phosphorylation of the receptor and regulation of its mRNA level. J Biol Chem 264:16786-16792 (Pubitemid 19243577)
11. Braak H, Del Tredici K, Rüb U, de Vos RAI, Jansen Steur ENH, Braak E (2003) Staging of brain pathology related to sporadic Parkinson's disease. Neurobiol Aging 24:197-211 (Pubitemid 36007810)
12. Camp S, Zhang L, Marquez M, de la Torre B, Long JM, Bucht G, Taylor P (2005) Acetylcholinesterase (AChE) gene modification in transgenic animals: functional consequences of selected exon and regulatory region deletion. Chem Biol Interact 157-158:79-86 (Pubitemid 41757637)
13. Coyle JT, Price DL, DeLong MR (1983) Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 219:1184-1190 (Pubitemid 13160659)
14. Davis KL, Berger PA (1978) Pharmacological investigations of the cholinergic imbalance hypotheses of movement disorders and psychosis. Biol Psychiatry 13:23-49 (Pubitemid 8285216)
15. De Castro BM, Pereira GS, Magalhães V, Rossato JI, De Jaeger X, Martins-Silva C, Leles B, Lima P, Gomez MV, Gainetdinov RR et al (2009) Reduced expression of the vesicular acetylcholine transporter causes learning deficits in mice. Genes Brain Behav 8:23-35
16. De Jaeger X, CammarotaM, PradoMAM, Izquierdo I, Prado VF, Pereira GS (2013) Decreased acetylcholine release delays the consolidation of object recognition memory. Behav Brain Res 238:62-68
17. Dobbertin A, Hrabovska A, Dembele K, Camp S, Taylor P, Krejci E, Bernard V (2009) Targeting of acetylcholinesterase in neurons in vivo: a dual processing function for the proline-rich membrane anchor subunit and the attachment domain on the catalytic subunit. J Neurosci 29:4519-4530
18. Duysen EG, Stribley JA, Fry DL, Hinrichs SH, Lockridge O (2002) Rescue of the acetylcholinesterase knockout mouse by feeding a liquid diet; phenotype of the adult acetylcholinesterase deficient mouse. Brain Res Dev Brain Res 137:43-54 (Pubitemid 34786635)
19. Duysen EG, Li B, Darvesh S, Lockridge O (2007) Sensitivity of butyrylcholinesterase knockout mice to (-)-huperzine A and donepezil suggests humans with butyrylcholinesterase deficiency may not tolerate these Alzheimer's disease drugs and indicates butyrylcholinesterase function in neurotransmission. Toxicology 233:60-69
20. Farar V, Mohr F, LegrandM, Lamotte d'Incamps B, Cendelin J, Leroy J, AbitbolM, Bernard V, Baud F, FournetVet al (2012) Near-complete adaptation of the PRiMA knockout to the lack of central acetylcholinesterase. J Neurochem 122:1065-1080
21. Farar V, Hrabovska A, Krejci E, Myslivecek J (2013) Developmental adaptation of central nervous system to extremely high acetylcholine levels. PloS One 8:e68265
22. Farlow MR, Cummings JL (2007) Effective pharmacologic management of Alzheimer's disease. Am J Med 120:388-397 (Pubitemid 46627453)
23. Friedman MJ, Jaffe JH (1969) A central hypothermic response to pilocarpine in the mouse. J Pharmacol Exp Ther 167:34-44
24. Gordon CJ, Heath JE (1986) Integration and central processing in temperature regulation. Annu Rev Physiol 48:595-612 (Pubitemid 16047636)
25. Grauer E, Levy A (2007) Oxotremorine-induced hypothermia as a method for evaluating long-term neuronal changes following poisoning by cholinesterase inhibitors in rats. Toxicology 242:1-6 (Pubitemid 350087425)
26. Hartmann J, Kiewert C, Duysen EG, Lockridge O, Greig NH, Klein J (2007) Excessive hippocampal acetylcholine levels in acetylcholinesterase-deficient mice are moderated by butyrylcholinesterase activity. J Neurochem 100:1421-1429
27. Hirano S, Shinotoh H, Shimada H, Aotsuka A, Tanaka N, Ota T, Sato K, Ito H, Kuwabara S, Fukushi K et al (2010) Cholinergic imaging in corticobasal syndrome, progressive supranuclear palsy and frontotemporal dementia. Brain J Neurol 133:2058-2068
28. Hirsch EC, Graybiel AM, Duyckaerts C, Javoy-Agid F (1987) Neuronal loss in the pedunculopontine tegmental nucleus in Parkinson disease and in progressive supranuclear palsy. Proc Natl Acad Sci U S A 84:5976-5980 (Pubitemid 17135731)
29. Hrabovska A, Duysen EG, Sanders JD, Murrin LC, Lockridge O (2005) Delivery of human acetylcholinesterase by adeno-associated virus to the acetylcholinesterase knockout mouse. Chem Biol Interact 157-158:71-78 (Pubitemid 41757636)
30. Hrabovska A, Farar V, Bernard V, Duysen EG, Brabec J, Lockridge O, Myslivecek J (2010) Drastic decrease in dopamine receptor levels in the striatum of acetylcholinesterase knock-out mouse. Chem Biol Interact 183:194-201
31. Jellinger K (1988) The pedunculopontine nucleus in Parkinson's disease, progressive supranuclear palsy and Alzheimer's disease. J Neurol Neurosurg Psychiatry 51:540-543
32. Lee J, Hwang YJ, Shin JY, Lee WC, Wie J, Kim KY, Lee MY, Hwang D, Ratan RR, Pae AN et al (2013) Epigenetic regulation of cholinergic receptor M1 (CHRM1) by histone H3K9me3 impairs Ca(2+) signaling in Huntington's disease. Acta Neuropathol (Berl) 125:727-739
33. Li B, Duysen EG, Volpicelli-Daley LA, Levey AI, Lockridge O (2003) Regulation of muscarinic acetylcholine receptor function in acetylcholinesterase knockout mice. Pharmacol Biochem Behav 74:977-986 (Pubitemid 36351661)
34. Mallick BN, Joseph MM (1997) Role of cholinergic inputs to the medial preoptic area in regulation of sleep-wakefulness and body temperature in freely moving rats. Brain Res 750:311-317 (Pubitemid 27116277)
35. Massoulié J, Bon S (2006) The C-terminal T peptide of cholinesterases: structure, interactions, and influence on protein folding and secretion. J Mol Neurosci MN 30:233-236 (Pubitemid 46035375)
36. Massoulié J, Perrier N, Noureddine H, Liang D, Bon S (2008) Old and new questions about cholinesterases. Chem Biol Interact 175:30-44
37. Mohr F, Zimmermann M, Klein J (2013) Mice heterozygous for AChE are more sensitive to AChE inhibitors but do not respond to BuChE inhibition. Neuropharmacology 67:37-45
38. Moser VC (1995) Comparisons of the acute effects of cholinesterase inhibitors using a neurobehavioral screening battery in rats. Neurotoxicol Teratol 17:617-625
39. Myers RD, Yaksh TL (1969) Control of body temperature in the unanaesthetized monkey by cholinergic and aminergic systems in the hypothalamus. J Physiol 202:483-500
40. Pepeu G, Giovannini MG (2010) Cholinesterase inhibitors and memory. Chem Biol Interact 187:403-408
41. Perrier AL, Massoulié J, Krejci E (2002) PRiMA: the membrane anchor of acetylcholinesterase in the brain. Neuron 33:275-285 (Pubitemid 34127759)
42. Perrier NA, Khérif S, Perrier AL, Dumas S, Mallet J, Massoulié J (2003) Expression of PRiMA in the mouse brain: membrane anchoring and accumulation of "tailed" acetylcholinesterase. Eur J Neurosci 18:1837-1847 (Pubitemid 37372367)
43. Pisani A, Bonsi P, Picconi B, Tolu M, Giacomini P, Scarnati E (2001) Role of tonically-active neurons in the control of striatal function: cellular mechanisms and behavioral correlates. Prog Neuropsychopharmacol Biol Psychiatry 25:211-230 (Pubitemid 32173793)
44. Pope C, Karanth S, Liu J (2005) Pharmacology and toxicology of cholinesterase inhibitors: uses and misuses of a common mechanism of action. Environ Toxicol Pharmacol 19:433-446
45. Prado VF, Martins-Silva C, de Castro BM, Lima RF, Barros DM, Amaral E, Ramsey AJ, Sotnikova TD, Ramirez MR, Kim H-G et al (2006) Mice deficient for the vesicular acetylcholine transporter are myasthenic and have deficits in object and social recognition. Neuron 51:601-612 (Pubitemid 44314080)
46. Prado VF, Roy A, Kolisnyk B, Gros R, Prado MAM (2013) Regulation of cholinergic activity by the vesicular acetylcholine transporter. Biochem J 450:265-274
47. Robinson L, Platt B, Riedel G (2011) Involvement of the cholinergic system in conditioning and perceptual memory. Behav Brain Res 221:443-465
48. Rochester L, Yarnall AJ, Baker MR, David RV, Lord S, Galna B, Burn DJ (2012) Cholinergic dysfunction contributes to gait disturbance in early Parkinson's disease. Brain J Neurol 135:2779-2788
49. Scarr E, Gibbons AS, Neo J, Udawela M, Dean B (2013) Cholinergic connectivity: it's implications for psychiatric disorders. Front Cell Neurosci 7:55
50. Simon S, Krejci E, Massoulié J (1998) A four-to-one association between peptide motifs: four C-terminal domains from cholinesterase assemble with one proline-rich attachment domain (PRAD) in the secretory pathway. EMBO J 17:6178-6187 (Pubitemid 28497791)
51. Smith R, Chung H, Rundquist S, Maat-Schieman MLC, Colgan L, Englund E, Liu YJ, Roos RAC, Faull RLM, Brundin P et al (2006) Cholinergic neuronal defect without cell loss in Huntington's disease. Hum Mol Genet 15:3119-3131 (Pubitemid 44605494)
52. Smith Y, Raju D, Nanda B, Pare J-F, Galvan A, Wichmann T (2009) The thalamostriatal systems: anatomical and functional organization in normal and parkinsonian states. Brain Res Bull 78:60-68
53. Sun M, Lee CJ, Shin HS (2007) Reduced nicotinic receptor function in sympathetic ganglia is responsible for the hypothermia in the acetylcholinesterase knockout mouse. J Physiol 578:751-764 (Pubitemid 46165507)
54. Terry AV Jr (2008) Role of the central cholinergic system in the therapeutics of schizophrenia. Curr Neuropharmacol 6:286-292
55. Wenning GK, Ebersbach G, Verny M, Chaudhuri KR, Jellinger K, McKee A, Poewe W, Litvan I (1999) Progression of falls in postmortem-confirmed Parkinsonian disorders. Mov Disord Off J Mov Disord Soc 14:947-950
56. Whitehouse PJ, Price DL, Struble RG, Clark AW, Coyle JT, Delon MR (1982) Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain. Science 215:1237-1239 (Pubitemid 12106486)
57. Xie W, Wilder PJ, Stribley J, Chatonnet A, Rizzino A, Taylor P, Hinrichs SH, LockridgeO (1999) Knockout of one acetylcholinesterase allele in the mouse. Chem Biol Interact 119-120:289-299 (Pubitemid 29278564)
58. Xie W, Stribley JA, Chatonnet A, Wilder PJ, Rizzino A, McComb RD, Taylor P, Hinrichs SH, Lockridge O (2000) Postnatal developmental delay and supersensitivity to organophosphate in gene-targeted mice lacking acetylcholinesterase. J Pharmacol Exp Ther 293:896-902 (Pubitemid 30417856)
59. Yarnall A, Rochester L, Burn DJ (2011) The interplay of cholinergic function, attention, and falls in Parkinson's disease. Mov Disord Off J Mov Disord Soc 26:2496-2503
60. Yoburn BC, Purohit V, Patel K, Zhang Q (2004) Opioid agonist and antagonist treatment differentially regulates immunoreactive mu-opioid receptors and dynamin-2 in vivo. Eur J Pharmacol 498:87-96 (Pubitemid 39208065)